Atlas Trials

Non-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT®

Clinical trial NCT00684645 · COMPLETED

Trial details

NCT number
NCT00684645
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Renal Cell Carcinoma
Start date
2008-06-01
Primary completion
2011-04-01
Enrollment
186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.